Show simple item record

DIABETIC KETOACIDOSIS WITH MILD HYPERGLYCEMIA ASSOCIATED WITH THE USE OF CANAGLIFLOZIN. REPORT OF ONE CASE WITH TYPE 1 DIABETES

Cetoacidosis diabética euglicémica asociada a inhibidor de cotransportador de sodio glucosa Tipo 2 en paciente con diabetes Mellitus Tipo 1

dc.contributoren-US
dc.contributores-ES
dc.creatorNovik A, Victoria; Hospital Dr.Gustavo Fricke, Viña del Mar, Universidad de Valparaíso, Universidad Andrés Bello
dc.creatorGarcía B, Claudia; Universidad de Valparaíso
dc.creatorOliva I, Daniela; Hospital de Quillota
dc.date2017-03-01
dc.date.accessioned2019-11-11T18:27:49Z
dc.date.available2019-11-11T18:27:49Z
dc.identifierhttp://www.revistamedicadechile.cl/ojs/index.php/rmedica/article/view/5356
dc.identifier.urihttps://revistaschilenas.uchile.cl/handle/2250/111292
dc.descriptionDiabetic ketoacidosis with mild hyperglycemia is a major complication of sodium-glucose cotransporter 2 inhibitors. Although its use is not approved for patients with type 1 diabetes mellitus, the drug is often prescribed with the hope of optimizing metabolic control. We report a 20 years old female with hypothyroidism and type 1 diabetes consulting for vomiting and abdominal pain. The patient had used canagliflozin during the two previous months. Laboratory showed a blood glucose of 200 mg/dl, a severe metabolic acidosis (pH 7.1) and ketonemia. The patient was successfully treated in the intensive care unit.en-US
dc.descriptionDiabetic ketoacidosis with mild hyperglycemia is a major complication of sodium-glucose cotransporter 2 inhibitors. Although its use is not approved for patients with type 1 diabetes mellitus, the drug is often prescribed with the hope of optimizing metabolic control. We report a 20 years old female with hypothyroidism and type 1 diabetes consulting for vomiting and abdominal pain. The patient had used canagliflozin during the two previous months. Laboratory showed a blood glucose of 200 mg/dl, a severe metabolic acidosis (pH 7.1) and ketonemia. The patient was successfully treated in the intensive care unit.es-ES
dc.formatapplication/pdf
dc.languagespa
dc.publisherRevista Médica de Chilees-ES
dc.relationhttp://www.revistamedicadechile.cl/ojs/index.php/rmedica/article/view/5356/2885
dc.relationhttp://www.revistamedicadechile.cl/ojs/index.php/rmedica/article/downloadSuppFile/5356/25276
dc.relationhttp://www.revistamedicadechile.cl/ojs/index.php/rmedica/article/downloadSuppFile/5356/25277
dc.relationhttp://www.revistamedicadechile.cl/ojs/index.php/rmedica/article/downloadSuppFile/5356/25278
dc.relationhttp://www.revistamedicadechile.cl/ojs/index.php/rmedica/article/downloadSuppFile/5356/25279
dc.relationhttp://www.revistamedicadechile.cl/ojs/index.php/rmedica/article/downloadSuppFile/5356/25280
dc.relationhttp://www.revistamedicadechile.cl/ojs/index.php/rmedica/article/downloadSuppFile/5356/25439
dc.relationhttp://www.revistamedicadechile.cl/ojs/index.php/rmedica/article/downloadSuppFile/5356/26673
dc.sourceRevista Médica de Chile; Vol. 145, núm. 3 (2017): MARZO 2017es-ES
dc.source0034-9887
dc.subjectDiabetes Mellitus, Type 1; Diabetic Ketoacidosis; Glycosuria; Hyperglycemiaen-US
dc.subjectDiabetes Mellitus, Type 1; Diabetic Ketoacidosis; Glycosuria; Hyperglycemiaes-ES
dc.titleDIABETIC KETOACIDOSIS WITH MILD HYPERGLYCEMIA ASSOCIATED WITH THE USE OF CANAGLIFLOZIN. REPORT OF ONE CASE WITH TYPE 1 DIABETESen-US
dc.titleCetoacidosis diabética euglicémica asociada a inhibidor de cotransportador de sodio glucosa Tipo 2 en paciente con diabetes Mellitus Tipo 1es-ES
dc.typeinfo:eu-repo/semantics/article
dc.typeinfo:eu-repo/semantics/publishedVersion
dc.typees-ES


This item appears in the following Collection(s)

Show simple item record